CKD Hyperphosphataemia — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Calcium carbonate
Calcium-based phosphate binders (calcium carbonate with meals) remain first-line for hyperphosphataemia in CKD due to efficacy and low cost. However, total elemental calcium from binders should not exceed 1500 mg/day to avoid vascular calcification. Non-calcium-based binders (sevelamer, lanthanum) are preferred if serum calcium is elevated, PTH is suppressed, or vascular calcification is present. Aluminium-based binders are avoided due to aluminium toxicity risk.
Reference: KHA-CARI – 2013 – CKD-MBD Guidelines; KDIGO – 2017 – CKD-MBD Update